109 related articles for article (PubMed ID: 30594552)
1. Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study.
Jensen PN; Fretts AM; Yu C; Hoofnagle AN; Umans JG; Howard BV; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; McKnight B; Lemaitre RN
EBioMedicine; 2019 Mar; 41():44-49. PubMed ID: 30594552
[TBL] [Abstract][Full Text] [Related]
2. Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort.
Dagogo-Jack S; Asuzu P; Wan J; Grambergs R; Stentz F; Mandal N
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38501230
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular events.
Lidgard B; Bansal N; Zelnick LR; Hoofnagle AN; Fretts AM; Longstreth WT; Shlipak MG; Siscovick DS; Umans JG; Lemaitre RN
EBioMedicine; 2023 Sep; 95():104765. PubMed ID: 37634384
[TBL] [Abstract][Full Text] [Related]
4. Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes.
Brady EM; Cao TH; Moss AJ; Athithan L; Ayton SL; Redman E; Argyridou S; Graham-Brown MPM; Maxwell CB; Jones DJL; Ng L; Yates T; Davies MJ; McCann GP; Gulsin GS
BMC Cardiovasc Disord; 2024 Jan; 24(1):25. PubMed ID: 38172712
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism.
Kayser BD; Prifti E; Lhomme M; Belda E; Dao MC; Aron-Wisnewsky J; ; Kontush A; Zucker JD; Rizkalla SW; Dugail I; Clément K
Metabolomics; 2019 Oct; 15(11):140. PubMed ID: 31605240
[TBL] [Abstract][Full Text] [Related]
6. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
[TBL] [Abstract][Full Text] [Related]
7. Associations of plasma sphingolipid profiles with insulin response during oral glucose testing in Icelandic horses.
Leung YH; Kenéz Á; Grob AJ; Feige K; Warnken T
J Vet Intern Med; 2021 Jul; 35(4):2009-2018. PubMed ID: 34105193
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans.
Bae JC; Wander PL; Lemaitre RN; Fretts AM; Sitlani CM; Bui HH; Thomas MK; Leonetti D; Fujimoto WY; Boyko EJ; Utzschneider KM
Nutr Metab Cardiovasc Dis; 2024 Mar; 34(3):633-641. PubMed ID: 38161124
[TBL] [Abstract][Full Text] [Related]
9. Plasma Sphingolipid Profile of Healthy Black and White Adults Differs Based on Their Parental History of Type 2 Diabetes.
Mandal N; Stentz F; Asuzu PC; Nyenwe E; Wan J; Dagogo-Jack S
J Clin Endocrinol Metab; 2024 Feb; 109(3):740-749. PubMed ID: 37804534
[TBL] [Abstract][Full Text] [Related]
10. Associations of NAFLD with circulating ceramides and impaired glycemia.
Gadgil MD; Sarkar M; Sands C; Lewis MR; Herrington DM; Kanaya AM
Diabetes Res Clin Pract; 2022 Apr; 186():109829. PubMed ID: 35292328
[TBL] [Abstract][Full Text] [Related]
11. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease.
Poss AM; Maschek JA; Cox JE; Hauner BJ; Hopkins PN; Hunt SC; Holland WL; Summers SA; Playdon MC
J Clin Invest; 2020 Mar; 130(3):1363-1376. PubMed ID: 31743112
[TBL] [Abstract][Full Text] [Related]
12. Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study.
Moseholm KF; Horn JW; Fitzpatrick AL; Djoussé L; Longstreth WT; Lopez OL; Hoofnagle AN; Jensen MK; Lemaitre RN; Mukamal KJ
Front Neurol; 2024; 15():1385623. PubMed ID: 38765262
[TBL] [Abstract][Full Text] [Related]
13. Plasma ceramides relate to mild cognitive impairment in middle-aged men: The Maastricht Study.
van Kruining D; Losen M; Crivelli SM; de Jong JJA; Jansen JFA; Backes WH; Monereo-Sánchez J; van Boxtel MPJ; Köhler S; Linden DEJ; Schram MT; Mielke MM; Martinez-Martinez P
Alzheimers Dement (Amst); 2023; 15(3):e12459. PubMed ID: 37675435
[TBL] [Abstract][Full Text] [Related]
14. Association between serum sphingolipids and eudaimonic well-being in white U.S. adults.
Berkowitz L; Henríquez MP; Salazar C; Rojas E; Echeverría G; Love GD; Rigotti A; Coe CL; Ryff CD
Sci Rep; 2021 Jun; 11(1):13139. PubMed ID: 34162955
[TBL] [Abstract][Full Text] [Related]
15. Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications.
Hammad SM; Lopes-Virella MF
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762318
[TBL] [Abstract][Full Text] [Related]
16. Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study.
Gharib AR; Jensen PN; Psaty BM; Hoofnagle AN; Siscovick D; Gharib SA; Sitlani CM; Sotoodehnia N; Lemaitre RN
ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37020834
[TBL] [Abstract][Full Text] [Related]
17. Very long-chain saturated fatty acids and diabetes and cardiovascular disease.
Lemaitre RN; King IB
Curr Opin Lipidol; 2022 Feb; 33(1):76-82. PubMed ID: 34907969
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of erythrocyte sphingolipid levels as potential cardiovascular health markers in women from Libya and Serbia: a small-scale study.
Vidović N; Knez M; Ranić M; Faid F; Jović D; Glibetic M; Takić M
Libyan J Med; 2023 Dec; 18(1):2264568. PubMed ID: 37804002
[No Abstract] [Full Text] [Related]
19. Is Plasma 16:0 ceramide a marker of cardiovascular risk?
Saleh C
Diabetes Metab; 2024 Jun; ():101553. PubMed ID: 38942075
[No Abstract] [Full Text] [Related]
20. CerS1-Derived C
Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
